Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Czechia

European Research Council grant · Running

REWIRE Deciphering Replication Readiness and Its Role in Genome Duplication Surveillance

Coordinator
Biofyzikalni Ustav Akademie Ved Ceske Republiky, Czechia
Runs
1 January 2027 to 31 December 2031
Status
Running
EU funding
€2.0m
Total cost
€2.0m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101301269

What the project is doing

In the project's own words, from its summary on CORDIS.

Errors in DNA replication are a major driver of human disease—up to two-thirds of all cancers originate from faults in this process. While we understand how cells replicate their DNA once the process begins, we know far less about how they prepare for this critical event. How do cells determine they are ready to copy their genome, and what happens when this readiness fails?Building on recent discoveries from my lab, I propose that before entering S phase, cells undergo a tightly regulated state of replication readiness—an inheritable condition that preconfigures accurate genome duplication across generations.

My data suggest this readiness precedes the G1 phase and relies on the mother cell passing the key molecular components of replication readiness to daughter cells. This creates a form of cellular memory that ensures replication fidelity across generations. The REWIRE project will define how replication readiness is established, monitored, and re-established under stress. I hypothesize the existence of a previously unrecognized G2/M surveillance mechanism—a maternal replication readiness checkpoint—safeguarding the handover of replication competence to progeny.

I will also investigate how this process is established de novo during tissue regeneration—a costly and error-prone transition that may compromise genome stability. To this end, I will use advanced tools developed in my lab, including inducible protein degradation, CRISPR-based editing, and AI-assisted single-cell and single-molecule imaging pipelines. Using small intestinal organoids, I will cross-examine inherited and de novo replication readiness and link it to tissue-level outcomes in regeneration and disease.

By uncovering how cells preconfigure genome duplication before it begins, REWIRE will redefine the logic of DNA replication control, reveal new mechanisms safeguarding genome stability, and uncover vulnerabilities that could be targeted in cancer and other replication-driven disorders.

Topics

Who is involved

OrganisationCityCountryRole
Biofyzikalni Ustav Akademie Ved Ceske RepublikyBrnoCzechiaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI